SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Endocyte, Inc. Intent to Seek Conditional Marketing Authorization in the European Union for Targeted Therapeutic EC145 and Companion Imaging Diagnostic EC20 for Platinum-Resistant Ovarian Cancer